In Case You Missed It
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
The most ethnically and gender diverse boards may surprise you.
It doesn't really matter where you think a stock should trade at.
Baxter buys generic drug maker Claris Injectables in a deal that will be accretive to earnings.
By acquiring Claris, Baxter expects to launch seven to nine new generic injectable medicines each year over the next several years.
©1996-2017 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.